Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy

被引:102
作者
Lenert, JT
Barnett, CC
Kudelka, AP
Sellin, RV
Gagel, RF
Prieto, VG
Skibber, JM
Ross, MI
Pisters, PWT
Curley, SA
Evans, DB
Lee, JE
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Med Therapeut, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
D O I
10.1067/msy.2001.118369
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Adrenal abnormalities are often identified on imaging studies performed during the staging of Patients Presenting with a new malignancy or restaging of patients with a history of a malignancy. Methods. M reviewed the records of patients who underwent surgical resection of an adrenal mass identified in the setting of previously or newly diagnosed extra-adrenal malignancy. Results. Eighty-one patients with an adrenal mass and recently diagnosed malignancy (n = 24) or history of a malignancy (n = 57) underwent adrenalectomy. In 42 patients (52%) the adrenal mass was a metastasis. In 39 patients (48%) the adrenal mass was an additional primary adrenal tumor process: 19 pheochromocytomas, (14 syndrome-associated, 5 sporadic), 13 cortical adenomas, 3 adrenocoritcal carcinomas, 2 ganglioneuromas, and 2 cases of nodular hyperplasia. Conclusions. In this series nearly half of the patients with cancer and an adrenal mass had adrenal pathologic condition independent of their primary malignancy. Despite the presence of a newly diagnosed malignancy or history of malignancy, all patients with an adrenal mass should undergo a standard hormone evaluation to confirm that the mass is not a functional neoplasm. An assumption that the adrenal mass is metastatic disease will be wrong in zip to 50% of such patients.
引用
收藏
页码:1060 / 1067
页数:8
相关论文
共 26 条
[1]   SERENDIPITOUS ADRENAL MASSES - PREVALENCE, SIGNIFICANCE, AND MANAGEMENT [J].
ABECASSIS, M ;
MCLOUGHLIN, MJ ;
LANGER, B ;
KUDLOW, JE .
AMERICAN JOURNAL OF SURGERY, 1985, 149 (06) :783-788
[2]   Limitations of size as a criterion in the evaluation of adrenal tumors [J].
Barnett, CC ;
Varma, DG ;
El-Naggar, AK ;
Dackiw, APB ;
Porter, GA ;
Pearson, AS ;
Kudelka, AP ;
Gagel, RF ;
Evans, DB ;
Lee, JE .
SURGERY, 2000, 128 (06) :973-982
[3]  
Beitler AL, 1998, J SURG ONCOL, V69, P54, DOI 10.1002/(SICI)1096-9098(199809)69:1<54::AID-JSO11>3.0.CO
[4]  
2-N
[5]  
BELLDEGRUN A, 1986, SURG GYNECOL OBSTET, V163, P203
[6]  
BRANUM GD, 1991, SURGERY, V109, P127
[7]   PIGMENTED PHEOCHROMOCYTOMAS OF THE ADRENAL-MEDULLA [J].
CHETTY, R ;
CLARK, SP ;
TAYLOR, DA .
HUMAN PATHOLOGY, 1993, 24 (04) :420-423
[8]   Screening for MEN1 mutations in patients with atypical endocrine neoplasia [J].
Dackiw, APB ;
Cote, GJ ;
Fleming, JB ;
Schultz, PN ;
Stanford, P ;
Vassilopoulou-Sellin, R ;
Evans, DB ;
Gagel, RF ;
Lee, JE .
SURGERY, 1999, 126 (06) :1097-1103
[9]   PROSPECTIVE EVALUATION OF UNILATERAL ADRENAL MASSES IN PATIENTS WITH OPERABLE NON-SMALL-CELL LUNG-CANCER [J].
ETTINGHAUSEN, SE ;
BURT, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1462-1466
[10]  
FARAJ BA, 1981, CLIN CHEM, V27, P108